MiR-495 enhances the sensitivity of non-small cell lung cancer cells to platinum by modulation of copper-transporting P-type adenosine triphosphatase A (ATP7A)

Journal of Cellular Biochemistry

Volumn 115, Issue 7, 2014, Pages 1234-1242

  Song, Liqiang ^a   Li, Yan ^a   Li, Weina ^b   Wu, Shouzhen ^b   Li, Zhikui ^a  

^a FOURTH MILITARY MEDICAL UNIVERSITY   (China)

^b FOURTH MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

ATP7A; CISPLATIN (CDDP); microRNAs; miR 495; PLATINUM

Indexed keywords

CISPLATIN; MENKES PROTEIN; MICRORNA; MICRORNA 495; UNCLASSIFIED DRUG; 3' UNTRANSLATED REGION; ADENOSINE TRIPHOSPHATASE; ANTINEOPLASTIC AGENT; ATP7A PROTEIN, HUMAN; CARBOPLATIN; CATION TRANSPORT PROTEIN; MIRN495 MICRORNA, HUMAN; PACLITAXEL; SMALL INTERFERING RNA; TUMOR MARKER;

ADULT; AGED; ARTICLE; BINDING SITE; CANCER CELL; CELL SURVIVAL; CELL VIABILITY; CLINICAL ARTICLE; CONTROLLED STUDY; DOWN REGULATION; FEMALE; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; LUNG NON SMALL CELL CANCER; MALE; MIDDLE AGED; MULTIDRUG RESISTANCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; REPORTER GENE; 3' UNTRANSLATED REGION; BIOSYNTHESIS; CARCINOMA, NON-SMALL-CELL LUNG; DRUG RESISTANCE; GENE EXPRESSION REGULATION; GENETICS; LUNG NEOPLASMS; MOLECULAR CLONING; PHYSIOLOGY; RNA INTERFERENCE; TUMOR CELL LINE;

3' UNTRANSLATED REGIONS; ADENOSINE TRIPHOSPHATASES; AGED; ANTINEOPLASTIC AGENTS; BINDING SITES; CARBOPLATIN; CARCINOMA, NON-SMALL-CELL LUNG; CATION TRANSPORT PROTEINS; CELL LINE, TUMOR; CISPLATIN; CLONING, MOLECULAR; DRUG RESISTANCE, NEOPLASM; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; LUNG NEOPLASMS; MALE; MICRORNAS; MIDDLE AGED; PACLITAXEL; RNA INTERFERENCE; RNA, SMALL INTERFERING; TUMOR MARKERS, BIOLOGICAL;

EID: 84899995519     PISSN: 07302312     EISSN: 10974644     Source Type: Journal    
DOI: 10.1002/jcb.24665     Document Type: Article

References (31)

1. Ambros V,. 2004. The functions of animal microRNAs. Nature 431: 350-355.
2. Bartel DP,. 2004. MicroRNAs: Genomics, biogenesis, mechanism, and function. Cell 116: 281-297.
3. Brennecke J, Hipfner DR, Stark A, Russell RB, Cohen SM,. 2003. Bantam encodes a developmentally regulated microRNA that controls cell proliferation and regulates the proapoptotic gene hid in Drosophila. Cell 113: 25-36.
4. Chen PS, Su JL, Cha ST, Tarn WY, Wang MY, Hsu HC, Lin MT, Chu CY, Hua KT, Chen CN, Kuo TC, Chang KJ, Hsiao M, Chang YW, Chen JS, Yang PC, Kuo ML,. 2011. miR-107 promotes tumor progression by targeting the let-7 microRNA in mice and humans. J Clin Invest 121: 3442-3455.
5. Feng B, Wang R, Song HZ, Chen LB,. 2012. MicroRNA-200b reverses chemoresistance of docetaxel-resistant human lung adenocarcinoma cells by targeting E2F3. Cancer 118: 3365-3376.
6. Guo L, Liu Y, Bai Y, Sun Y, Xiao F, Guo Y,. 2010. Gene expression profiling of drug-resistant small cell lung cancer cells by combining microRNA and cDNA expression analysis. Eur J Cancer 46: 1692-1702.
7. Hanada K, Nagai N, Ogata H,. 1995. Quantitative determination of unchanged cisplatin in rat kidney liver by high-performance liquid chromatography. J Chromatogr B Biomed Appl 663 (1): 181-186.
8. Holleman A, Chung I, Olsen RR, Kwak B, Mizokami A, Saijo N, Parissenti A, Duan Z, Voest EE, Zetter BR,. 2011. miR-135a contributes to paclitaxel resistance in tumor cells both in vitro and in vivo. Oncogene 30: 4386-4398.
9. Huang Y, Anderle P, Bussey KJ, Barbacioru C, Shankavaram U, Dai Z, Reinhold WC, Papp A, Weinstein JN, Sadee W,. 2004. Membrane transporters and channels: Role of the transportome in cancer chemosensitivity and chemoresistance. Cancer Res 64: 4294-4301.
10. Hwang-Verslues WW, Chang PH, Wei PC, Yang CY, Huang CK, Kuo WH, Shew JY, Chang KJ, Lee EY, Lee WH,. 2011. miR-495 is upregulated by E12/E47 in breast cancer stem cells, and promotes oncogenesis and hypoxia resistance via downregulation of E-cadherin and REDD1. Oncogene 30: 2463-2474.
11. Inoue Y, Matsumoto H, Yamada S, Kawai K, Suemizu H, Gika M, Takanami I, Iwazaki M, Nakamura M,. 2010. Association of ATP7A expression and in vitro sensitivity to cisplatin in non-small cell lung cancer. Oncol Lett 1: 837-840.
12. Jiang X, Huang H, Li Z, He C, Li Y, Chen P, Gurbuxani S, Arnovitz S, Hong GM, Price C, Ren H, Kunjamma RB, Neilly MB, Salat J, Wunderlich M, Slany RK, Zhang Y, Larson RA, Le Beau MM, Mulloy JC, Rowley JD, Chen J,. 2012. miR-495 is a tumor-suppressor microRNA down-regulated in MLL-rearranged leukemia. Proc Natl Acad Sci USA 109: 19397-19402.
13. Kalayda GV, Wagner CH, Buss I, Reedijk J, Jaehde U,. 2008. Altered localisation of the copper efflux transporters ATP7A and ATP7B associated with cisplatin resistance in human ovarian carcinoma cells. BMC Cancer 8: 175.
14. Kovalchuk O, Filkowski J, Meservy J, Ilnytskyy Y, Tryndyak VP, Chekhun VF, Pogribny IP,. 2008. Involvement of microRNA-451 in resistance of the MCF-7 breast cancer cells to chemotherapeutic drug doxorubicin. Mol Cancer Ther 7: 2152-2159.
15. Kuo MT, Chen HH, Song IS, Savaraj N, Ishikawa T,. 2007. The roles of copper transporters in cisplatin resistance. Cancer Metastasis Rev 26: 71-83.
16. Li Z, Cao Y, Jie Z, Liu Y, Li Y, Li J, Zhu G, Liu Z, Tu Y, Peng G, Lee DW, Park SS,. 2012a. miR-495 and miR-551a inhibit the migration and invasion of human gastric cancer cells by directly interacting with PRL-3. Cancer Lett 323: 41-47.
17. Li ZH, Qiu MZ, Zeng ZL, Luo HY, Wu WJ, Wang F, Wang ZQ, Zhang DS, Li YH, Xu RH,. 2012b. Copper-transporting P-type adenosine triphosphatase (ATP7A) is associated with platinum-resistance in non-small cell lung cancer (NSCLC). J Transl Med 10: 21.
18. Matsumoto S, Tanaka T, Kurokawa H, Matsuno K, Hayashida Y, Takahashi T,. 2007. Effect of copper and role of the copper transporters ATP7A and CTR1 in intracellular accumulation of cisplatin. Anticancer Res 27: 2209-2216.
19. Meng F, Henson R, Lang M, Wehbe H, Maheshwari S, Mendell JT, Jiang J, Schmittgen TD, Patel T,. 2006. Involvement of human micro-RNA in growth and response to chemotherapy in human cholangiocarcinoma cell lines. Gastroenterology 130: 2113-2129.
20. Pogribny IP, Filkowski JN, Tryndyak VP, Golubov A, Shpyleva SI, Kovalchuk O,. 2010. Alterations of microRNAs and their targets are associated with acquired resistance of MCF-7 breast cancer cells to cisplatin. Int J Cancer 127: 1785-1794.
21. Samimi G, Safaei R, Katano K, Holzer AK, Rochdi M, Tomioka M, Goodman M, Howell SB,. 2004. Increased expression of the copper efflux transporter ATP7A mediates resistance to cisplatin, carboplatin, and oxaliplatin in ovarian cancer cells. Clin Cancer Res 10: 4661-4669.
22. Song B, Wang Y, Titmus MA, Botchkina G, Formentini A, Kornmann M, Ju J,. 2010. Molecular mechanism of chemoresistance by miR-215 in osteosarcoma and colon cancer cells. Mol Cancer 9: 96.
23. Tiseo M, Franciosi V, Grossi F, Ardizzoni A,. 2006. Adjuvant chemotherapy for non-small cell lung cancer: ready for clinical practice ? Eur J Cancer 42: 8-16.
24. To KK, Robey RW, Knutsen T, Zhan Z, Ried T, Bates SE,. 2009. Escape from hsa-miR-519c enables drug-resistant cells to maintain high expression of ABCG2. Mol Cancer Ther 8: 2959-2968.
25. Wu Y, Xiao Y, Ding X, Zhuo Y, Ren P, Zhou C, Zhou J,. 2011. A miR-200b/200c/429-binding site polymorphism in the 3′ untranslated region of the AP-2alpha gene is associated with cisplatin resistance. PLoS ONE 6: e29043.
26. Xia L, Zhang D, Du R, Pan Y, Zhao L, Sun S, Hong L, Liu J, Fan D,. 2008. miR-15b and miR-16 modulate multidrug resistance by targeting BCL2 in human gastric cancer cells. Int J Cancer 123: 372-379.
27. Yang H, Kong W, He L, Zhao JJ, O'Donnell JD, Wang J, Wenham RM, Coppola D, Kruk PA, Nicosia SV, Cheng JQ,. 2008. MicroRNA expression profiling in human ovarian cancer: miR-214 induces cell survival and cisplatin resistance by targeting PTEN. Cancer Res 68: 425-433.
28. Ying Q, Liang L, Guo W, Zha R, Tian Q, Huang S, Yao J, Ding J, Bao M, Ge C, Yao M, Li J, He X,. 2011. Hypoxia-inducible microRNA-210 augments the metastatic potential of tumor cells by targeting vacuole membrane protein 1 in hepatocellular carcinoma. Hepatology 54: 2064-2075.
29. Yoshizawa K, Nozaki S, Kitahara H, Ohara T, Kato K, Kawashiri S, Yamamoto E,. 2007. Copper efflux transporter (ATP7B) contributes to the acquisition of cisplatin-resistance in human oral squamous cell lines. Oncol Rep 18: 987-991.
30. Zhu W, Xu H, Zhu D, Zhi H, Wang T, Wang J, Jiang B, Shu Y, Liu P,. 2012a. miR-200bc/429 cluster modulates multidrug resistance of human cancer cell lines by targeting BCL2 and XIAP. Cancer Chemother Pharmacol 69: 723-731.
31. Zhu W, Zhu D, Lu S, Wang T, Wang J, Jiang B, Shu Y, Liu P,. 2012b. miR-497 modulates multidrug resistance of human cancer cell lines by targeting BCL2. Med Oncol 29: 384-391.